Since the implementation of the Affordable Care Act, more and more individuals are gaining access to insurance. Therefore, part of the New Jersey Health Care Quality Institute's responsibility is to make the complexities of the healthcare industry more easily understandable for members, according to Linda Schwimmer, JD, president and CEO of the New Jersey Health Care Quality Institute
Since the implementation of the Affordable Care Act, more and more individuals are gaining access to insurance. Therefore, part of the New Jersey Health Care Quality Institute's responsibility is to make the complexities of the healthcare industry more easily understandable for members, according to Linda Schwimmer, JD, president and CEO of the New Jersey Health Care Quality Institute
Transcript (slightly modified)
What role does the New Jersey Health Care Quality Institute provide for the state and its healthcare providers?
One of the important roles of the Quality Institute is that we are great translators. Healthcare’s really complicated and one of the things that the Affordable Care Act did that I’m so excited about is it really enabled so many more people to have health insurance, which is really sort of your entry way to getting healthcare, comprehensive healthcare, in the United States. Like it or not, that’s the system that we have and so through the Medicaid expansion, we have in New Jersey 400,000 more people who now have healthcare and through the subsidies, through the marketplace, hopefully they’ll be upheld by the courts in a couple of weeks. But through the subsidies, we also have about 200,000 more people in New Jersey that were able to purchase health insurance, who wouldn’t have been able to purchase it if they hadn’t had that sort of subsidy.
So for a lot of people, health insurance is new to them and health insurance is very complicated and the medical system’s very complicated so that and then all the other people who were in the healthcare system but still had a lot of questions, we’re able to sort of be that bridge to explain things that are complicated in bite-size pieces, in English, to sort of take some of the fear of it and to help people be better consumers of healthcare. I think that’s unique in that we have that deep knowledge but …we do our best to explain it as simply as possible.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More